Coglapix Edition 1
A field trial performed with Coglapix® in The Netherlands is described in a farm presenting Actinobacillus pleuropneumoniae infection.
Using a veterinary application, “VetApp”, which has been developed to follow-up the health status on pig farms during the monthly farm visits, a reduction of the coughing index has been associated with a drop of mortality by approximately 50% and the antibiotic use was reduced to almost zero after the introduction of the vaccine.
Coglapix Edition 2
The distribution of various serotypes of Actinobacillus pleuropneumoniae differs substantially among countries.
The presence of various serotypes in a farm as well as in a given area doesn’t stay stable, but evolves over the time.
Serotype 8 is the most prevalent in the UK and was isolated also in other countries as highly virulent. In an experimental challenge trial, Coglapix® documented high efficacy against the serotype 8 of A. pleuropneumoniae.
There was the lowest rate of clinical symptoms and no mortality in pigs vaccinated with Coglapix®.
Coglapix Edition 3
Lung scoring together with serological profiling of the herd is a useful approach to assess prevalence and severity of some important respiratory pathogens and determine a most efficient vaccination program.
Dr Andrea Luppi from Izsler Institute is sharing the main conclusion of a large epidemiological study performed in Italy. This study demonstrates that:
the Enzootic Pneumonia (EP)-like lesions average values show significant associations with the intra herd seroprevalence for M.hyo at 18 weeks of age, confirming a good correlation between the EP like lesions recorded at the slaughter house and previous M.hyo infection.
Dorso-caudal pleurisy average value and Actinobacilluspleuropneumonaie index (API) are significantly associated to A.p herd seroprevalence.
These evaluations confirm once again the importance of the scoring of the lungs at the slaughterhouse, in order to discover pleural lesions due to sub-clinical cases and bronchopneumonia lesions, otherwise often under estimated…
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.